Companion Genetics was founded by people who built NGS diagnostics for human patients — now bringing that same rigor to the animals we live with.
We're an early-stage, cross-functional team, and we're still pre-launch in a few important ways — so for now we're introducing ourselves by expertise rather than by name. Full bios are available directly to veterinary partners, investors, and grant reviewers on request.
Why we do it this way: our core contributors have deep experience at recognized biotech and biopharma organizations, and we'd rather introduce everyone properly, with full bios and context, once we're further along. Reach out and we're happy to share more directly.
Panel design, variant-calling pipelines, and cloud infrastructure — background in biotech bioinformatics.
Experience shipping products at a large biopharma company, applied here to kit design and reporting.
Clinical and translational science background from human oncology therapeutics companies. Leads BD and patent strategy.
Assay protocol development and CRO relationship management, from sample intake through sequencing.
Includes a co-author of the peer-reviewed feline oncogenome study this panel is built on. Leads clinical indications and report design.
Background in biologics drug discovery, applied to matching tumor mutations with existing therapies.
Leads cat-owner community engagement and consumer marketing.
15+ years in healthcare software, now applied to our web presence and data infrastructure strategy.
PhD-level research support, plus competitive and market-sizing analysis.
Combined, the team has shipped biotech and biopharma programs at organizations including Vor Biopharma, Vaxxart, TScan Therapeutics, AstraZeneca, Intellia Therapeutics, Moderna, and Takeda Biologics.
If you want to bring human-grade precision medicine to veterinary care, we'd like to hear from you.
Get in touch